Bistability in Glycolysis Pathway as a Physiological Switch in Energy Metabolism

The flux of glycolysis is tightly controlled by feed-back and feed-forward allosteric regulations to maintain the body's glucose homeostasis and to respond to cell's growth and energetic needs. Using a mathematical model based on reported mechanisms for the allosteric regulations of the enzymes, we demonstrate that glycolysis exhibits multiple steady state behavior segregating glucose metabolism into high flux and low flux states. Two regulatory loops centering on phosphofructokinase and on pyruvate kinase each gives rise to the bistable behavior, and together impose more complex flux control. Steady state multiplicity endows glycolysis with a robust switch to transit between the two flux states. Under physiological glucose concentrations the glycolysis flux does not move between the states easily without an external stimulus such as hormonal, signaling or oncogenic cues. Distinct combination of isozymes in glycolysis gives different cell types the versatility in their response to different biosynthetic and energetic needs. Insights from the switch behavior of glycolysis may reveal new means of metabolic intervention in the treatment of cancer and other metabolic disorders through suppression of glycolysis.

[1]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[2]  Ruiqiang Li,et al.  Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells , 2013, Nature Structural &Molecular Biology.

[3]  B. Corkey,et al.  Phosphofructokinase Isozymes in Pancreatic Islets and Clonal β-Cells (INS-1) , 1995, Diabetes.

[4]  R. Sakakibara,et al.  Kinetic studies of fructose 6-phosphate,2-kinase and fructose 2,6-bisphosphatase. , 1984, The Journal of biological chemistry.

[5]  D. da Silva,et al.  Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. , 2010, Molecular genetics and metabolism.

[6]  J. Gunawardena,et al.  Unlimited multistability in multisite phosphorylation systems , 2009, Nature.

[7]  M. V. Vander Heiden,et al.  Allosteric Regulation of PKM2 Allows Cellular Adaptation to Different Physiological States , 2013, Science Signaling.

[8]  J. Ferrell,et al.  A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2003, Nature.

[9]  N. Manes,et al.  The kinase activity of human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is regulated via inhibition by phosphoenolpyruvate. , 2005, Archives of biochemistry and biophysics.

[10]  C. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[11]  P W Kuchel,et al.  Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement. , 1999, The Biochemical journal.

[12]  M. Walkinshaw,et al.  M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation , 2013, Proceedings of the National Academy of Sciences.

[13]  Jason W Locasale,et al.  Metabolic flux and the regulation of mammalian cell growth. , 2011, Cell metabolism.

[14]  John O Trent,et al.  Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth , 2008, Molecular Cancer Therapeutics.

[15]  A. Sols,et al.  Specific activation by fructose 2,6-bisphosphate and inhibition by P-enolpyruvate of ascites tumor phosphofructokinase. , 1982, Biochemical and biophysical research communications.

[16]  Wei-Shou Hu,et al.  On metabolic shift to lactate consumption in fed-batch culture of mammalian cells. , 2012, Metabolic engineering.

[17]  A. Terzic,et al.  Metabolic plasticity in stem cell homeostasis and differentiation. , 2012, Cell stem cell.

[18]  A. Krainer,et al.  The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism , 2010, Proceedings of the National Academy of Sciences.

[19]  Meike T. Wortel,et al.  Lost in Transition: Start-Up of Glycolysis Yields Subpopulations of Nongrowing Cells , 2014, Science.

[20]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[21]  S. Khan,et al.  Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes. , 2006, Advances in enzyme regulation.

[22]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[23]  R. Bartrons,et al.  PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. , 2001, Trends in biochemical sciences.

[24]  J. Lowenstein,et al.  Control of phosphofructokinase from rat skeletal muscle. Effects of fructose diphosphate, AMP, ATP, and citrate. , 1976, The Journal of biological chemistry.

[25]  Wei-Shou Hu,et al.  Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways. , 2010, Trends in biotechnology.

[26]  L. Lashinger,et al.  Calorie restriction and cancer prevention: a mechanistic perspective , 2013, Cancer & metabolism.

[27]  E. Kandel,et al.  Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.

[28]  T. Noguchi,et al.  Nutrient and hormonal regulation of pyruvate kinase gene expression. , 1999, The Biochemical journal.

[29]  B. Wright,et al.  Cellular concentrations of enzymes and their substrates. , 1990, Journal of theoretical biology.

[30]  J. Weinstein,et al.  Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers , 2013, Oncotarget.

[31]  Andre Terzic,et al.  Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. , 2011, Cell metabolism.

[32]  Young-Sam Lee,et al.  SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions , 2012, Science.

[33]  R. Sakakibara,et al.  Effect of replacement of the amino and the carboxyl termini of rat testis fructose 6-phosphate, 2-kinase:fructose 2,6-bisphosphatase with those of the liver and heart isozymes. , 1997, Archives of biochemistry and biophysics.

[34]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[35]  Cole Trapnell,et al.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.

[36]  R. Moreno-Sánchez,et al.  HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. , 2009, Mini reviews in medicinal chemistry.

[37]  John Eric Wilson.  Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function , 2003, Journal of Experimental Biology.

[38]  G. Staal,et al.  Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies. , 1985, The Biochemical journal.

[39]  I. van Mechelen,et al.  Using Ribosomal Protein Genes as Reference: A Tale of Caution , 2008, PloS one.

[40]  B. Corkey,et al.  Phosphofructokinase isozymes in pancreatic islets and clonal beta-cells (INS-1). , 1995, Diabetes.

[41]  A. Levine,et al.  The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.

[42]  R. Moreno-Sánchez,et al.  Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells , 2012, Journal of cellular biochemistry.

[43]  E. Schaftingen,et al.  Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Chesney.  6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis , 2006, Current opinion in clinical nutrition and metabolic care.

[45]  Eyal Gottlieb,et al.  Serine is a natural ligand and allosteric activator of pyruvate kinase M2 , 2012, Nature.

[46]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[47]  G. Reinhart,et al.  Rat liver phosphofructokinase: kinetic activity under near-physiological conditions. , 1980, Biochemistry.

[48]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[49]  G. Daley,et al.  Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. , 2012, Cell stem cell.

[50]  Tiago Costa Leite,et al.  Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis. , 2007, The Biochemical journal.

[51]  Philip Cayting,et al.  An encyclopedia of mouse DNA elements (Mouse ENCODE) , 2012, Genome Biology.

[52]  C. Verfaillie,et al.  Expansion and hepatic differentiation of rat multipotent adult progenitor cells in microcarrier suspension culture. , 2010, Journal of biotechnology.

[53]  T. Sugimura,et al.  Multiple forms of phosphofructokinase in rat tissues and rat tumors. , 1972, Biochemical and biophysical research communications.

[54]  Tae J. Lee,et al.  A bistable Rb–E2F switch underlies the restriction point , 2008, Nature Cell Biology.

[55]  M. Sola-Penna,et al.  Lactate downregulates the glycolytic enzymes hexokinase and phosphofructokinase in diverse tissues from mice , 2011, FEBS letters.

[56]  C. Thompson,et al.  Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. , 2004, Molecular cell.

[57]  Jing Chen,et al.  Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth , 2009, Science Signaling.

[58]  G. Cottam,et al.  Glucagon-stimulated phosphorylation of pyruvate kinase in hepatocytes. , 1978, The Journal of biological chemistry.

[59]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[60]  T. Griffin,et al.  Quantitative Nuclear Proteomics Identifies mTOR Regulation of DNA Damage Response* , 2009, Molecular & Cellular Proteomics.

[61]  A. Schulze,et al.  Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism , 2013, Cancer & Metabolism.

[62]  M. Kretschmer,et al.  Inhibition of rat liver phosphofructokinase-2 by phosphoenolpyruvate and ADP. , 1984, Biochemical and biophysical research communications.